bf/NASDAQ:LYEL_icon.jpeg

COM:LYELL

Lyell Immunopharma, Inc.

  • Stock

Last Close

0.92

22/11 21:00

Market Cap

402.80M

Beta: -

Volume Today

1.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
asset turnover
0.00
-
0.00
9.50%
0.00
23.34%
0.00
7.59%
0.00
8.88%
0.00
79.39%
0.03
6,682.12%
0.00
99.99%
0.00
1,581.18%
0.00
43.05%
0.00
56.22%
0.00
2.71%
0.00
44.88%
0.00
75.07%
0.00
359.88%
0.00
176.29%
cash conversion cycle
-76.97
-
-85.73
11.38%
-77.11
-
cash per share
2.89
-
2.49
13.89%
19.30
674.89%
2.59
86.61%
2.57
0.67%
2.51
2.10%
2.66
5.86%
2.61
1.93%
2.57
1.68%
2.46
4.33%
2.38
3.02%
2.29
3.84%
2.16
5.74%
2.07
4.09%
1.92
7.10%
1.72
10.62%
company equity multiplier
1.26
-
1.30
2.50%
1.20
7.13%
1.21
0.94%
1.21
0.18%
1.22
0.33%
1.18
3.25%
1.19
1.25%
1.13
5.59%
1.12
0.17%
1.13
0.93%
1.14
0.53%
1.15
0.48%
1.15
0.51%
1.15
0.32%
1.17
1.05%
days of inventory outstanding
days of payables outstanding
76.97
-
85.73
11.38%
77.11
-
days of sales outstanding
dividend yield
ebit per revenue
-26.28
-
-32.89
25.18%
-34.43
4.68%
-17.10
50.35%
-22.65
32.47%
-23.86
5.36%
-17.84
25.22%
-16.85
5.60%
-124.01
636.14%
-1.04
99.16%
-22.15K
2,124,127.13%
-0.17
100.00%
-962.40
554,463.37%
-2.44K
153.63%
-2.36K
3.25%
-4.60K
94.88%
-363.33
92.11%
-4.10K
1,028.38%
-21.47
99.48%
ebt per ebit
0.89
-
0.98
10.77%
0.97
1.21%
0.98
1.41%
0.99
1.12%
1.00
0.41%
0.99
0.40%
1.76
77.11%
0.99
43.57%
0.97
1.90%
1.06
8.48%
1
5.43%
1.07
7.04%
0.97
9.43%
0.86
11.15%
0.88
2.71%
55.66
6,191.34%
0.86
98.46%
61.07
7,005.56%
effective tax rate
0.08
-
0.02
76.66%
0.03
64.20%
0.03
8.03%
0.01
80.60%
0.00
45.85%
0.01
58.62%
0.00
30.15%
0.01
64.29%
0.03
307.35%
-0.05
310.39%
291.41
536,462.88%
-0.98
100.34%
0.04
103.74%
0.13
254.64%
enterprise value multiple
-91.68
-
-73.29
20.06%
-3.19
95.64%
-71.33
2,133.20%
-37.86
46.93%
-16.74
55.78%
-44.31
164.68%
-31.13
29.76%
-241.30K
775,100.91%
-11.39
100.00%
-10.90
4.29%
-2.63
75.89%
-7.46
183.68%
-443.83
5,850.97%
-6.83
98.46%
-417.60
6,018.26%
fixed asset turnover
0.02
-
0.02
9.44%
0.02
1.48%
0.02
1.60%
0.02
0.25%
0.00
80.95%
0.21
6,324.36%
0.00
99.99%
0.00
1,547.26%
0.00
38.74%
0.00
56.91%
0.00
3.37%
0.00
45.67%
0.00
75.95%
0.00
352.35%
0.00
174.30%
free cash flow per share
-0.14
-
-0.45
215.03%
-0.16
64.30%
-0.24
50.61%
-0.22
10.82%
-1.37
528.90%
-0.16
88.65%
-0.18
16.99%
-0.24
29.96%
-0.21
11.34%
-0.16
23.17%
-0.18
11.90%
-0.19
6.40%
-0.16
16.23%
-0.15
5.94%
-0.16
6.59%
-0.17
2.93%
-0.15
9.02%
-0.14
8.98%
gross profit margin
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
-203.16
20,416%
-388
90.98%
1
100.26%
-376
37,700%
1
100.27%
interest coverage
-14.10
-
-54.53
286.77%
-33.62
38.35%
-63.65
89.33%
-156.41
145.75%
-287.65
83.90%
-182.08
36.70%
-147.18
19.17%
-172.74
17.37%
-39.14
77.34%
-29.51
24.59%
0.00
100.01%
-0.95
40,938.87%
inventory turnover
long term debt to capitalization
0.07
-
0.08
18.70%
0.06
27.83%
0.06
10.03%
0.07
7.14%
0.07
6.33%
0.07
0.54%
0.07
3.29%
0.07
3.55%
0.07
3.75%
0.08
3.34%
0.08
2.53%
0.08
3.17%
0.08
4.83%
0.09
2.67%
0.09
2.72%
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
1
0%
0.99
0.63%
0.97
1.96%
1.05
8.23%
-290.41
27,644.81%
1.98
100.68%
1
49.51%
1
0%
1
0%
1
0%
1
0%
1
0%
net profit margin
-23.28
-
-32.28
38.67%
-33.38
3.41%
-16.81
49.65%
-22.51
33.95%
-23.82
5.80%
-17.74
25.52%
-29.66
67.20%
-122.44
312.80%
-0.99
99.19%
-24.69K
2,493,773.69%
50.40
100.20%
-2.04K
4,148.62%
-2.37K
15.97%
-2.03K
14.04%
-4.07K
100.16%
-20.22K
396.68%
-3.52K
82.57%
-1.31K
62.79%
operating cash flow per share
-0.11
-
-0.42
276.92%
-0.10
75.68%
-0.13
23.60%
-0.14
9.59%
-0.79
474.44%
-0.11
86.58%
-0.14
29.93%
-0.20
41.42%
-0.18
8.16%
-0.15
16.99%
-0.16
8.03%
-0.19
14.71%
-0.16
15.47%
-0.15
4.19%
-0.16
7.07%
-0.17
2.92%
-0.15
9.74%
-0.14
8.34%
operating cycle
operating profit margin
-26.28
-
-32.89
25.18%
-34.43
4.68%
-17.10
50.35%
-22.65
32.47%
-23.86
5.36%
-17.84
25.22%
-16.85
5.60%
-124.01
636.14%
-1.04
99.16%
-22.15K
2,124,127.13%
-0.17
100.00%
-962.40
554,463.37%
-2.44K
153.63%
-2.36K
3.25%
-4.60K
94.88%
-363.33
92.11%
-4.10K
1,028.38%
-21.47
99.48%
payables turnover
1.17
-
1.05
10.22%
1.17
-
pretax profit margin
-23.28
-
-32.28
38.67%
-33.38
3.41%
-16.81
49.65%
-22.51
33.95%
-23.82
5.80%
-17.74
25.52%
-29.66
67.20%
-123.23
315.43%
-1.02
99.18%
-23.42K
2,304,177.56%
-0.17
100.00%
-1.03K
593,496.28%
-2.37K
129.71%
-2.03K
14.04%
-4.07K
100.16%
-20.22K
396.68%
-3.52K
82.57%
-1.31K
62.79%
price fair value
4.98
-
6.06
21.71%
0.68
88.80%
3.59
429.12%
1.99
44.51%
1.40
29.78%
1.85
32.22%
2.22
19.98%
1.04
53.20%
0.75
27.66%
1.08
43.69%
0.53
50.95%
0.75
41.55%
0.92
22.58%
0.71
22.49%
0.67
6.43%
receivables turnover
return on assets
-0.04
-
-0.06
46.68%
-0.05
18.89%
-0.04
19.86%
-0.07
82.04%
-0.06
14.93%
-0.03
45.16%
-0.08
118.84%
0.00
103.43%
-0.15
5,891.56%
-0.08
49.23%
-0.06
16.36%
-0.07
10.32%
-0.09
23.83%
-0.07
19.86%
-0.07
2.81%
return on capital employed
-0.05
-
-0.07
46.69%
-0.05
20.33%
-0.04
19.73%
-0.04
1.92%
-0.07
51.20%
-0.04
42.33%
-0.07
87.03%
-0.00
99.99%
-0.07
789,492.21%
-0.08
11.76%
-0.08
5.58%
-0.08
7.63%
-0.00
98.03%
-0.09
5,092.49%
-0.00
98.54%
return on equity
-0.05
-
-0.08
50.34%
-0.06
24.67%
-0.05
19.11%
-0.09
81.71%
-0.08
14.65%
-0.04
46.95%
-0.09
121.59%
0.00
103.24%
-0.17
5,881.72%
-0.09
48.76%
-0.07
15.92%
-0.08
10.86%
-0.10
24.46%
-0.08
19.61%
-0.08
3.89%
total debt to capitalization
0.07
-
0.11
56.02%
0.08
28.75%
0.08
7.33%
0.07
19.30%
0.07
4.62%
0.07
0.54%
0.07
3.29%
0.08
2.85%
0.07
2.71%
0.08
3.34%
0.08
12.24%
0.09
3.73%
0.08
4.74%
0.10
14.68%
0.09
8.04%

All numbers in (except ratios and percentages)